Stay updated on CBDV Safety & Tolerability in ASD Clinical Trial
Sign up to get notified when there's something new on the CBDV Safety & Tolerability in ASD Clinical Trial page.

Latest updates to the CBDV Safety & Tolerability in ASD Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe page shows a new revision label: v3.3.2, replacing the previous v3.3.1. This appears to be a minor site/template update with no changes to the study details, eligibility criteria, or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check21 days agoChange DetectedRevision label updated from v3.2.0 to v3.3.1; no study details, eligibility criteria, or navigation appear affected. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check28 days agoChange DetectedThe page no longer shows the government funding operating-status notice that previously warned about updates and responses; this notice did not influence the trial information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check43 days agoChange DetectedThe screenshots show only minor UI and layout adjustments on the Study Details page, with no changes to core trial data such as status, enrollment, or eligibility. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check71 days agoChange DetectedThe page now includes an operating-status notice and a version update to v3.2.0, while removing the previous v3.1.0 reference.SummaryDifference4%

- Check79 days agoChange DetectedUpdated the page revision from v3.0.2 to v3.1.0, indicating a new software release or document update. No changes to core content, pricing, or stock are evident.SummaryDifference0.1%

Stay in the know with updates to CBDV Safety & Tolerability in ASD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CBDV Safety & Tolerability in ASD Clinical Trial page.